# ABC (NCT02374242)

> Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02374242
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Melanoma Institute Australia
- Conditions: Melanoma; Brain Metastases
- Interventions: Nivolumab; Ipilimumab
- Enrollment: 76
- Primary outcome: Intracranial response rate

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 134
- Podcasts: 21
- YouTube: 17
- X threads: 15

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=abc-nct02374242

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02374242", "email": "<work email>"}; the inbox owner confirms by the emailed link.